Mesangiogenic Progenitor Cells Derived from One Novel CD64 bright CD31 bright CD14 neg Population in Human Adult Bone Marrow
Open Access
- 15 March 2016
- journal article
- research article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 25 (9) , 661-673
Abstract
Mesenchymal stromal cells (MSCs) have been the object of extensive research for decades, due to their intrinsic clinical value. Nonetheless, the unambiguous identification of a unique in vivo MSC progenitor is still lacking, and the hypothesis that these multipotent cells could possibly arise from different in vivo precursors has been gaining consensus in the last years. We identified a novel multipotent cell population in human adult bone marrow that we first named Mesodermal Progenitor Cells (MPCs) for the ability to differentiate toward the mesenchymal lineage, while still retaining angiogenic potential. Despite extensive characterization, MPCs positioning within the differentiation pathway and whether they can be ascribed as possible distinctive progenitor of the MSC lineage is still unclear. In this study, we describe the ex vivo isolation of one novel bone marrow subpopulation ( Pop#8 ) with the ability to generate MPCs. Multicolor flow cytometry in combination with either fluorescence-activated cell sorting or magnetic-activated cell sorting were applied to characterize Pop#8 as CD64 bright CD31 bright CD14 neg . We defined Pop#8 properties in culture, including the potential of Pop#8 -derived MPCs to differentiate into MSCs. Gene expression data were suggestive of Pop#8 in vivo involvement in hematopoietic stem cell niche constitution/maintenance. Pop#8 resulted over three logs more frequent than other putative MSC progenitors, corroborating the idea that most of the controversies regarding culture-expanded MSCs could be the consequence of different culture conditions that select or promote particular subpopulations of precursors.Keywords
This publication has 48 references indexed in Scilit:
- Prospective Isolation of Murine and Human Bone Marrow Mesenchymal Stem Cells Based on Surface MarkersStem Cells International, 2013
- Clinical applications of mesenchymal stem cellsJournal of Hematology & Oncology, 2012
- Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selectionBone, 2012
- Mesodermal Progenitor Cells (MPCs) Differentiate into Mesenchymal Stromal Cells (MSCs) by Activation of Wnt5/Calmodulin Signalling PathwayPLOS ONE, 2011
- CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localizationBlood, 2011
- Mesenchymal and haematopoietic stem cells form a unique bone marrow nicheNature, 2010
- Mesenchymal stem cell therapy: Two steps forward, one step backTrends in Molecular Medicine, 2010
- Identification and Purification of Mesodermal Progenitor Cells From Human Adult Bone MarrowStem Cells and Development, 2009
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001